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ABSTRACT
Objective To identify risk factors for pelvic
inﬂammatory disease (PID) in female students.
Methods We performed a prospective study set in 11
universities and 9 further education colleges in London.
In 2004–2006, 2529 sexually experienced, multiethnic,
female students, mean age 20.8 years, provided self-
taken vaginal samples and completed questionnaires at
recruitment to the Prevention of Pelvic Infection
chlamydia screening trial. After 12 months, they were
followed up by questionnaire backed by medical record
search and assessed for PID by blinded genitourinary
medicine physicians.
Results Of 2004 (79%) participants who reported
numbers of sexual partners during follow-up, 32 (1.6%,
95% CI 1.1% to 2.2%) were diagnosed with PID. The
strongest predictor of PID was baseline Chlamydia
trachomatis (relative risk (RR) 5.7, 95% CI 2.6 to 15.6).
After adjustment for baseline C. trachomatis, signiﬁcant
predictors of PID were ≥2 sexual partners or a new
sexual partner during follow-up (RR 4.0, 95% CI 1.8 to
8.5; RR 2.8, 95% CI 1.3 to 6.3), age <20 years (RR
3.3, 95% CI 1.5 to 7.0), recruitment from a further
education college rather than a university (RR 2.6, 95%
CI 1.3 to 5.3) and history at baseline of vaginal
discharge (RR 2.7, 95% CI 1.2 to 5.8) or pelvic pain
(RR 4.1, 95% CI 2.0 to 8.3) in the previous six months.
Bacterial vaginosis and Mycoplasma genitalium infection
were no longer signiﬁcantly associated with PID after
adjustment for baseline C. trachomatis.
Conclusions Multiple or new partners in the last
12 months, age <20 years and attending a further
education college rather than a university were risk
factors for PID after adjustment for baseline
C. trachomatis infection. Sexual health education and
screening programmes could be targeted at these
high-risk groups.
Trial registration number (ClinicalTrials.gov
NCT00115388).
INTRODUCTION
Pelvic inﬂammatory disease (PID) is common, often
asymptomatic, and may cause tubal infertility,
ectopic pregnancy and chronic pelvic pain, but case
deﬁnition lacks speciﬁcity.1–5 Chlamydia trachoma-
tis and Neisseria gonorrhoeae may cause respect-
ively 25–30%6 and 1–2%7 of PID in the UK, and
Mycoplasma genitalium8 and bacterial vaginosis
(BV)9 may have a role, but in up to 70% of PID
cases no pathogens are found.8
Using data from the Prevention of Pelvic
Infection (POPI) chlamydia screening trial,10 the
main aim of this prospective study was to identify
risk factors for PID in young female students in an
education setting. In a secondary analysis, we
explored whether baseline BV or M. genitalium
might be risk factors for PID independent of base-
line chlamydial infection.
METHODS
Study population
The design of the POPI trial has been described
elsewhere.10 Brieﬂy, during 2004–2006, 2529
female students were recruited from 20 London
universities and further education colleges. (Further
education colleges take students from age 16 and
offer vocational subjects such as hairdressing as
well as A-levels and university entry preparation
courses to a diverse group of students. Courses are
usually free of charge to those under 19 years.)
Students were eligible to take part if they were
aged ≤27 years, female, sexually experienced, not
pregnant and had not been tested for C. trachoma-
tis in the previous three months. They were asked
to complete a questionnaire and to provide two
self-taken vaginal swabs. One swab was used for
the chlamydia screening trial. The other was rolled
over a glass slide for BV analysis, placed in Aptima
transport medium (Gen Probe), stored at −80°C
and later analysed for M. genitalium and
N. gonorrhoeae.8
Twelve-months follow-up
Figure 1 shows the design of this prospective study.
Initial follow-up was by emailed and postal ques-
tionnaires backed by telephone calls. The follow-up
questionnaire asked about development of PID or
related symptoms over the past 12 months. For
women with possible PID and those who did not
return questionnaires, we searched for clinical
details from general practitioners and/or hospital
records. We also did a medical record search in 65
women who reported being diagnosed with chla-
mydial infection during the 12-month follow-up
period.
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Diagnosis of possible PID
Since it would be unethical to demand a laparoscopic diagnosis,
we used modiﬁed Hager’s clinical criteria11 and the Centers for
Disease Control and Prevention guidelines12 to diagnose PID.
To reduce bias, conﬁrmation of the diagnosis was done by
review of all data (questionnaires backed by medical records) in
a two stage process by genitourinary medicine physicians (EW,
PEH and KP), resolved by PJH when there was disagreement,
all of whom were blind to baseline bacteriological tests and
group allocation.10 We included cases of PID who developed
symptoms or were seen by a healthcare professional during the
12-month follow-up period.
Statistical analysis
The sample size for this study was constrained by the 2529
women recruited to the chlamydia screening trial. As we were
looking at the development of PID for which change in sexual
partner may be an important behavioural risk factor,6 we
restricted analysis to the 2004 (79%) women who answered the
question on how many men they had had sexual intercourse
with during the 12-month follow-up. Risk factors evaluated
included age <20 years, black ethnicity, smoking, recruited at a
further education college rather than a university, ﬁrst sexual
intercourse before age 16, two or more partners in the year
prior to baseline or during 12-month follow-up, a new partner
during follow-up, baseline C. trachomatis, BV, M. genitalium or
N. gonorrhoeae; and symptoms of abnormal vaginal discharge,
pelvic pain, intermenstrual bleeding or dyspareunia in the previ-
ous six months at baseline. We did not include reports of these
symptoms during follow-up as a risk factor as this is part of the
diagnosis of PID.11 12
We used relative risks (RRs) to examine the relationship
between previously reported risk factors6 8 10 and development
of PID over 12 months. We adjusted for baseline chlamydial
infection as we wanted to see whether BV or M. genitalium
were associated with PID independent of chlamydial infection.
Further adjustment for potential confounders was not carried
out due to the small number of PID cases occurring during
follow-up. As these data come from a trial in which 63 women
in the intervention group with chlamydia at baseline were
referred for treatment, we also adjusted the RRs of chlamydia
causing PID for intervention or control group in a subsequent
analysis. Results were presented as RRs, and adjusted risks were
calculated using binominal regression.
RESULTS
Follow-up
Of 2529 women recruited to the trial, 2377 (94%) were fol-
lowed up after 12 months and 2004 (79%) completed the ques-
tion on numbers of sexual partners during follow-up.
Compared to the 2004 women with data on sexual partners
who were included in the study, the 525 women not included
were younger (mean age 19.9 years±2.5 vs 21.2 years±2.8,
p<0.001) and more likely to be of black ethnicity: 39.8% (483/
1514) vs 24.2% (205/310, p<0.001).
Risk factors for PID
Of the 2004 women, 32 (1.6%, 95% CI 1.1% to 2.2%) were
diagnosed with PID during follow-up. Table 1 shows that PID
was more common in women aged <20 years, those of black
ethnicity, those recruited from a further education college rather
than a university, those with baseline symptoms of vaginal dis-
charge or pelvic pain, and women with two or more sexual
partners or a new partner during the 12-month follow-up.
Overall, baseline infection with C. trachomatis was the strongest
risk factor for PID (RR 5.75, 95% CI 2.63 to 12.56).
Adjustment for intervention group scarcely changed this (RR
5.73, 95% CI 2.62 to 12.52).
Baseline BV or infection with M. genitalium were also asso-
ciated with PID.
Risk factors for PID after adjustment for baseline
C. trachomatis
Age <20 years, recruitment from a further education college,
baseline symptoms of vaginal discharge or pelvic pain, and mul-
tiple or new partners during follow-up remained signiﬁcant
after adjustment for baseline C. trachomatis. The adjusted RRs
for BV and M. genitalium were no longer signiﬁcant but
numbers were small, especially for M. genitalium.
DISCUSSION
Principal ﬁndings
The strongest risk factor for PID was baseline infection with C.
trachomatis, which increased the risk almost sixfold. After
adjustment for C. trachomatis, independent predictors of PID
were multiple or new sexual partners, age under 20 years,
attending a further education college rather than a university
and symptoms of vaginal discharge or pelvic pain at baseline.
Strengths and weaknesses
This is the ﬁrst UK education-based prospective study of PID.
Recruitment from educational institutions in London allowed
access to women not necessarily engaged with health services.
Around one in four women were of black ethnicity, which is
associated with poorer sexual health in the UK.13
The main limitation is that the clinical diagnosis of PID lacks
sensitivity and speciﬁcity3 and we only know about symptomatic
PID. This means we are likely to have missed some cases of PID
and also misdiagnosed some women with PID who did not have
PID. It was not possible to assess participants for PID at base-
line, and therefore, the PID identiﬁed at follow-up is likely to
include new cases that developed during the year (incident PID)
and cases that were present at the start of the study (prevalent
PID). In particular, where baseline symptoms of vaginal dis-
charge and pelvic pain were identiﬁed as predictors of PID, for
some women this may simply be reﬂecting an existing/prevalent
case of PID.
Figure 1 Flow of participants. GUM, genitourinary medicine; PID,
pelvic inﬂammatory disease.
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As only 32 cases of PID were diagnosed during follow–up,
multivariate analysis was not considered appropriate.
Consequently, we cannot determine whether the factors identi-
ﬁed as being associated with PID are independent of each other.
For example, students at further education colleges were on
average younger and more likely to be of black ethnicity than
those at university, which may confound our results. Further
studies would be needed to investigate independent effects
within these associations.
In addition, due to the small number of PID cases, many of
the adjusted RRs have wide CIs that include the possibility of
both no effect and a clinically important effect. However, this
data set still represents the largest education-based prospective
study of PID to date.
Rates of PID may be lower in this study as half the participants
were screened and treated for chlamydia as part of the clinical
trial. However, this is unlikely to have inﬂuenced the associations
found between PID and the other risk factors investigated. It was
not possible to obtain samples at the time of PID assessment, and
diagnoses were made retrospectively through follow-up question-
naires and a medical records search. Women who were excluded
because they did not complete the follow-up questionnaire were
younger and more likely to be of black ethnicity. However, PID
rates were similar in included and excluded women.
Results may not be generalisable to different populations,14
particularly those not in education, employment or training
(currently approximately 15% of women in England aged 16–
24 years15). Indeed, testing in educational settings may not yield
a high number of positive results for chlamydia.16 However, we
included further education colleges and universities in socio-
economically deprived areas of London, likely to have higher
rates of sexually transmitted infections.
Finally, the freezing and delayed testing of samples for M.
genitalium may have reduced sensitivity and therefore underesti-
mated the number of baseline infections.17
Comparison with other studies
As in previous reports, greater number of sexual partners and
younger age were associated with PID.14 18 19 We also found a
signiﬁcant association between recruitment from a further edu-
cation college (rather than a university) and PID. This ﬁnding
may reﬂect both lower socio-economic status,20 which has been
associated with PID,18 and the high proportion of sexually
active teenagers and women of black ethnicity10 recruited from
further education colleges. In contrast to other reports,3 we did
not ﬁnd smoking was associated with PID in our cohort.
We found an association between BV and PID, but once
adjusted for baseline C. trachomatis infection this association
was no longer signiﬁcant. Evidence remains inconclusive.9 21 22
M. genitalium was also associated with PID before adjustment,
but numbers were small with wide CIs. Previous reports23 24
identiﬁed M. genitalium as an independent risk factor for PID.
M. genitalium may be associated with fewer clinical symptoms
than C. trachomatis and more likely to cause ‘silent’ PID.24
Implications
Findings have implications for both health education and
screening programmes. Further education colleges may want to
consider including sexual health education as a compulsory part
of the curriculum. This might encourage testing in the context
of the identiﬁed risk factors, such as younger age, a change in
partner and pelvic pain and/or vaginal discharge. A recent quali-
tative study in a further education setting found that young
women value formal sexual health education and felt that
current provisions are insufﬁcient.25 In England, uptake of
yearly opportunistic screening for C. trachomatis is only 24% in
16–24 year olds.26 While screening for chlamydia will not
prevent every case of PID, these ﬁndings may encourage young
women most at risk to be more aware of their sexual health, to
engage in safer sex and to get tested for chlamydia after each
change of sexual partner.27 28
Table 1 PID during 12-month follow-up, related to demographic characteristics, sexual behaviour and baseline symptoms or co-infection in
2004 women
Characteristic
% with
characteristic
Cases of PID in
Relative risk
(95% CI)
Relative risk adjusted
for chlamydia (95% CI)
Women with
characteristic
Women without
characteristic
Age <20 years 39.9 2.84 (23/810) 0.75 (9/1194) 3.77 (1.75 to 8.10) 3.21 (1.48 to 6.96)
Black ethnicity 24.2 2.69 (13/483 1.25 (19/1514) 2.14 (1.07 to 4.3) 1.81 (0.87 to 3.73)
Smoker 30.4 1.81 (11/608) 1.51 (21/1392) 1.20 (0.58 to 2.47) 1.18 (0.57 to 2.44)
Further Education college versus university 26.4 3.03 (16/528) 1.08 (16/1475) 2.79 (1.41 to 5.55) 2.63 (1.31 to 5.30)
First sexual intercourse <16 years 28.4 1.61 (9/560) 1.56 (22/1392) 1.03 (0.48 to 2.23) 1.02 (0.47 to 13.10)
Two or more partners in year prior to baseline* 42.1 2.02 (17/842) 1.21 (14/1156) 1.67 (0.83 to 3.36) 1.60 (0.78 to 3.29)
Two or more partners during 12-month follow up 37.1 3.09 (23/744) 0.71 (9/1260) 4.33 (2.01 to 9.30) 3.95 (1.83 to 8.50)
New partner during 12-month follow-up 49.4 2.49 (24/965) 0.79 (8/1007) 3.07 (1.39 to 6.82) 2.82 (1.27 to 6.28)
Vaginal discharge in the past six months* 11.3 3.59 (8/223) 1.37 (24/1758) 2.63 (1.19 to 5.78) 2.66 (1.22 to 5.82)
Pelvic pain* 12.3 4.51 (11/244) 1.21 (21/1737) 3.73 (1.82 to 7.64) 4.07 (2.00 to 8.28)
Intermenstrual bleeding* 12.7 2.78 (7/252) 1.45 (25/1729) 1.92 (0.84 to 4.40) 1.90 (0.83 to 4.38)
Dyspareunia* 11.6 2.18 (5/229) 1.54 (27/1752) 1.42 (0.55 to 3.64) 1.13 (0.40 to 3.21)
Bacterial vaginosis
BV positive 20.5 2.94 (11/374) 1.38 (20/1449) 2.13 (1.03 to 4.41) 1.84 (0.88 to 3.88)
BV intermediate 1.4 1.2 (1/82) 1.38 (20/1449) 0.88 (0.12 to 6.50) 0.84 (0.11 to 6.24)
Chlamydia trachomatis* 5.7 7.02 (8/114) 1.22 (23/1883) 5.75 (2.63 to 12.56)
Mycoplasma genitalium* 3.2 5.08 (3/59) 1.47 (27/1811) 3.46 (1.08 to 11.09) 2.90 (0.89 to 9.44)
Neisseria gonorrhoeae* 0.4 0 (0/7) 1.58 (30/1901)
Bold text shows statistically significant relative risk.
*At baseline.
BV, bacterial vaginosis; PID, pelvic inflammatory disease.
Hay PE, et al. Sex Transm Infect 2016;92:63–66. doi:10.1136/sextrans-2015-052063 65
Epidemiology
group.bmj.com on May 25, 2016 - Published by http://sti.bmj.com/Downloaded from 
Key messages
▸ In this prospective study Chlamydia trachomatis infection
was the strongest risk factor for pelvic inﬂammatory disease.
▸ Multiple or new sexual partners in the last 12 months,
younger age and attending a further education college
rather than a university were also predictors.
▸ Policymakers could consider targeting sexual health
education at those with these risk factors.
Author afﬁliations
1Department of Genitourinary Medicine, Courtyard Clinic, St George’s Hospital,
London, UK
2Population Health Research Institute, St George’s, University of London,
London, UK
3School of Social and Community Medicine, University of Bristol, Bristol, UK
4Department of Primary Care & Public Health Sciences, Kings College London,
London, UK
5Pragmatic Clinical Trials Unit, Queen Mary’s, University of London, London, UK
6Homerton Sexual Health Services, Homerton University Hospital, London, UK
7Health Protection Services, Public Health England, London, UK
8Statens Serum Institut, Copenhagen, Denmark
Correction notice This article has been corrected since it was published Online
First. The article license has been updated.
Handling editor Jackie A Cassell
Acknowledgements We thank the students and staff at London Southbank
University; Kingston University; City University; St George’s, University of London;
Roehampton University; London College of Fashion; London College of
Communication; University of East London; Greenwich University; University of
Westminster; Wimbledon School of Art; Kingston College; Lambeth College;
Southwark College; South Thames College; Lewisham College; Bromley College;
North East Surrey College of Technology; Carshalton College; Merton College;
Coulsdon College; and Croydon College. We also thank research assistants Deborah
Banks, Ruth Harbit, and Stella Ivaz; research nurses Sally Dean and Cathy McKay;
peer recruiters Linzie Long, Michelle Lamb, Laura Proctor, Sarah Simms, and Sheila
Kerry, and grant administrator Frances Kazakos. We also thank Dr Harry Mallinson
and microbiology staff at Aintree Hospital Liverpool for doing the chlamydia tests;
Birthe Dohn for doing the M. genitalium tests; and the staff at the general practices,
genitourinary medicine clinics, sexual health clinics, and hospitals who provided
copies of medical records.
Contributors PEH, PO and SMK conceived and designed the study. SRK and FR
conducted the analysis. RN wrote the ﬁrst draft. All authors helped revise the article
and approved the ﬁnal version to be published. PO is guarantor.
Funding The BUPA Foundation (grant no. 684/GB14B) and Medical Research
Council (grant no. 80280). TMA sample collecting kits were provided by Gen-Probe
(San Diego, California, USA).
Competing interests PO is a member of the esti2 consortium which is funded
under the UKCRC Translational Infection Research Initiative supported by the
Medical Research Council (grant number G0901608) with contributions from the
Biotechnology and Biological Sciences Research Council, the National Institute for
Health Research on behalf of the Department of Health, the Chief Scientist Ofﬁce of
the Scottish Government Health Directorates and the Wellcome Trust. She is also is a
co-applicant on the NIHR South London Collaboration for Leadership in Applied
Health Research and Care.
Ethics approval Wandsworth research ethics committee and Bromley research
ethics committee.
Provenance and peer review Not commissioned; externally peer reviewed.
Open Access This is an Open Access article distributed in accordance with the
terms of the Creative Commons Attribution (CC BY 4.0) license, which permits
others to distribute, remix, adapt and build upon this work, for commercial use,
provided the original work is properly cited. See: http://creativecommons.org/
licenses/by/4.0/
REFERENCES
1 Gradison M. Pelvic inﬂammatory disease. Am Fam Physician 2012;85:791–6.
2 British Association for Sexual Health and HIV. Clinical Effectiveness Group. UK
National Guideline for the Management of Pelvic Inﬂammatory Disease. 2011
(updated June 2011).
3 Simms I, Rogers P, Charlett A. The rate of diagnosis and demography of pelvic
inﬂammatory disease in general practice: England and Wales. Int J STD AIDS
1999;10:448–51.
4 French CE, Hughes G, Nicholson A, et al. Estimation of the rate of pelvic
inﬂammatory disease diagnoses: trends in England, 2000–2008. Sex Transm Dis
2011;38:158–62.
5 Mitchell C, Prabhu M. Pelvic inﬂammatory disease: current concepts in
pathogenesis, diagnosis and treatment. Infect Dis North Am 2013;27:793–809.
6 Simms I, Stephenson JM. Pelvic inﬂammatory disease epidemiology: what do we
know and what do we need to know? Sex Transm Inf 2000;76:80–7.
7 Ross JDC, Hughes G. Why is the incidence of pelvic inﬂammatory disease falling?
BMJ 2013;346:f318.
8 Oakeshott P, Aghaizu A, Hay P, et al. Is Mycoplasma genitalium in Women the
“New Chlamydia?” A Community-Based Prospective Cohort Study. Clin Infect Dis
2010;51:1160–6.
9 Taylor BD, Darville T, Haggerty CL. Does bacterial vaginosis cause pelvic
inﬂammatory disease?. Sex Transm Dis 2013;40:117–22.
10 Oakeshott P, Kerry S, Aghaizu A, et al. Randomised controlled trial of screening for
Chlamydia trachomatis to prevent pelvic inﬂammatory disease: the POPI (prevention
of pelvic infection) trial. BMJ 2010;340:c1642.
11 Hager D, Eschenbach D. Criteria for diagnosis and grading of salpingitis. Obstet
Gynecol 1983;61:113–14.
12 Centers for Disease Control. Sexually transmitted diseases treatment guidelines.
MMWR 2006;55:56–7.
13 Health Protection Agency. Sexually transmitted infections in black African and black
Caribbean communities in the UK: 2008 report. http://www.hpa.org.uk/webc/
HPAwebFile/HPAweb_C/1225441603957 (April 2014).
14 Marks C, Tideman RL, Estcourt CS, et al. Assessment of risk for pelvic
inﬂammatory disease in an urban sexual health population. Sex Transm Inf
2000;76:470–3.
15 Department for Education. Statistics—national statistics. Statistics: NEET and
participation. NEET statistics quarterly brief: October to December 2014. https://
www.gov.uk/government/statistics/
neet-statistics-quarterly-brief-october-to-december-2014
16 Johnson SA, Simms I, Sheringham J, et al. The implementation of chlamydia
screening: a cross-sectional study in the South East of England. Sex Transm Infect
2010;86:217–21.
17 Hutton Carlsen K, Jensen JS. Mycoplasma genitalium PCR: does freezing of
specimens affect sensitivity? J Clin Microbiol 2010;48:3624–7.
18 Simms I, Stephenson JM, Mallinson H, et al. Risk factors associated with pelvic
inﬂammatory disease. Sex Transm Infect 2006;82:452–7.
19 Lee NC, Rubin GL, Grimes DA. Measures of sexual behavior and the risk of pelvic
inﬂammatory disease. Obstet Gynecol 1991;77:425–30.
20 Galindo-Rueda F, Marcenaro-Gutierrez O, Vignoles A. The Widening Socio-economic
Gap in UK Higher Education. Centre for the Economics of Education, 2004.
21 Ness RB, Hillier SL, Kip KE, et al. Bacterial vaginosis and risk of pelvic inﬂammatory
disease. Obstet Gynecol 2004;104:761–9.
22 Haggerty CL, Hillier SL, Bass DC, et al., PID Evaluation and Clinical Health (PEACH)
Study Investigators. Bacterial vaginosis and anaerobic bacteria are associated with
endometritis. Clin Infect Dis 2004;39:990–5.
23 Simms I, Eastick K, Mallinson H, et al. Associations between Mycoplasma
genitalium, Chlamydia trachomatis and pelvic inﬂammatory disease. Sex Transm
Infect 2003;79:154–6.
24 Bjartling C, Osser S, Persson K. Mycoplasma genitalium in cervicitis and pelvic
inﬂammatory disease among women at a gynecologic outpatient service. Am J
Obstet Gynecol 2012;206:476.e1–8.
25 Normansell R, Drennan VM, Oakeshott P. Exploring access and attitudes to regular
sexually transmitted infection screening: the views of young, multi-ethnic, inner-city,
female students. Health Expect Published Online First: 20 Feb 2015. doi:10.1111/
hex.12354
26 HPA Annual STI Data Tables. http://www.hpa.org.uk/stiannualdatatables (April
2014).
27 Price MJ, Ades AE, De Angelis D, et al. Risk of pelvic inﬂammatory disease
following Chlamydia trachomatis infection: analysis of prospective studies with a
multistate model. Am J Epidemiol 2013;178:484–92.
28 Aghaizu A, Reid F, Kerry S, et al. Frequency and risk factors for incident and
redetected Chlamydia trachomatis infection in sexually active, young, multi-ethnic
women: a community based cohort study. Sex Transm Infect 2014;90:524–8.
66 Hay PE, et al. Sex Transm Infect 2016;92:63–66. doi:10.1136/sextrans-2015-052063
Epidemiology
group.bmj.com on May 25, 2016 - Published by http://sti.bmj.com/Downloaded from 
disease? A prospective study
are most at risk of pelvic inflammatory 
Which sexually active young female students
Adamma Aghaizu, Jorgen Jensen and Pippa Oakeshott
Fiona Reid, Sally M Kerry, Katia Prime, Elizabeth Williams, Ian Simms, 
Phillip E Hay, Sarah R Kerry, Rebecca Normansell, Paddy J Horner,
doi: 10.1136/sextrans-2015-052063
2015
2016 92: 63-66 originally published online June 16,Sex Transm Infect 
 http://sti.bmj.com/content/92/1/63
Updated information and services can be found at: 
These include:
References
 #BIBLhttp://sti.bmj.com/content/92/1/63
This article cites 22 articles, 12 of which you can access for free at: 
Open Access
http://creativecommons.org/licenses/by/4.0/
use, provided the original work is properly cited. See: 
others to distribute, remix, adapt and build upon this work, for commercial
the Creative Commons Attribution (CC BY 4.0) license, which permits 
This is an Open Access article distributed in accordance with the terms of
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections 
 (462)Vulvovaginal disorders
 (677)Ophthalmology
 (950)Health education
 (3144)Drugs: infectious diseases
 (837)Chlamydia
 (974)Screening (public health)
 (974)Screening (epidemiology)
 (206)Open access
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on May 25, 2016 - Published by http://sti.bmj.com/Downloaded from 
